Holen Sie sich die Stockscreener-App
61.30
4.22%
-2.70
Handel nachbörslich:
61.30
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$64.00
Offen:
$62.45
24-Stunden-Volumen:
3.13M
Relative Volume:
0.97
Marktkapitalisierung:
$41.87B
Einnahmen:
$16.91B
Nettoeinkommen (Verlust:
$907.00M
KGV:
47.52
EPS:
1.29
Netto-Cashflow:
$1.55B
1W Leistung:
-1.83%
1M Leistung:
+1.49%
6M Leistung:
+5.53%
1J Leistung:
+6.78%
1-Tages-Spanne:
$61.09
$62.50
1-Wochen-Bereich:
$60.72
$64.03
52-Wochen-Spanne:
$50.01
$66.24
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Vergleichen Sie CTVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
61.30 | 41.87B | 16.91B | 907.00M | 1.55B | 1.29 |
|
NTR
Nutrien Ltd
|
50.71 | 24.77B | 26.56B | 733.00M | 2.33B | 1.49 |
|
CF
Cf Industries Holdings Inc
|
79.86 | 13.29B | 5.98B | 1.16B | 1.82B | 6.32 |
|
MOS
Mosaic Company
|
25.96 | 8.23B | 11.46B | 371.20M | 301.40M | 1.13 |
|
ICL
Icl Group Ltd
|
5.68 | 7.33B | 6.93B | 404.00M | 652.00M | 0.31 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2024-10-23 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-07 | Herabstufung | Argus | Buy → Hold |
| 2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
| 2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
| 2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-04-06 | Eingeleitet | Oppenheimer | Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
| 2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
| 2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-09-01 | Eingeleitet | Berenberg | Buy |
| 2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
| 2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
| 2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
Corteva Cumulative Preferred Stock About To Put More Money In Your Pocket - Nasdaq
Argus Research Upgrades Corteva (DB:2X0) - Nasdaq
Corteva upgraded to Buy at Argus on improving fundamentals, stabilizing prices - Yahoo Finance
Goldman Sachs Adjusts Price Target on Corteva to $73 From $71, Keeps Buy Rating - MarketScreener
Argus Upgrades Corteva Inc to Buy From Hold, Price Target is $69 - MarketScreener
Company unveils game-changing non-GMO seed that could solve growing global crisis: 'Revolutionary benefits' - MSN
Argus Research Upgrades Corteva (LSE:0A1W) - Nasdaq
Argus Research Upgrades Corteva (CTVA) - Nasdaq
The Analyst Verdict: Corteva In The Eyes Of 11 Experts - Benzinga
Argus Research Upgrades Corteva (BMV:CTVA) - Nasdaq
Argus raises Corteva stock rating to Buy, sets $69 target By Investing.com - Investing.com South Africa
Argus raises Corteva stock rating to Buy, sets $69 target - Investing.com India
Corteva upgraded at Argus Research on improved demand trends - MSN
Argus Upgrades Corteva to Buy From Hold, Price Target is $69 - MarketScreener
Corteva upgraded at Argus Research on improved demand trends (CTVA:NYSE) - Seeking Alpha
DnB Asset Management AS Has $13.27 Million Holdings in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Pure Market Inefficiency In Corteva Preferreds Pricings (NYSE:CTVA) - Seeking Alpha
(CTVA) Trading Report - news.stocktradersdaily.com
Corteva, Inc. (NYSE:CTVA) Shares Acquired by RiverFront Investment Group LLC - MarketBeat
Best Agriculture Stocks To Watch TodayMarch 25th - MarketBeat
Transgenic Crop Seeds Market Growth Probability, Key Vendors - openPR
Insect Resistant GM Crops Market Outlook 2025-2032: Growth - openPR
Herbicide Tolerant Crops Market Growth in Future Scope - openPR
Corteva Announces Dates for First Quarter 2025 Earnings Release and Webcast - Eastern Progress
BMO Capital Adjusts Price Target on Corteva to $74 From $72, Maintains Outperform Rating - Marketscreener.com
Corteva, IFC and SAFIA launch program to train 5 lakh rural entrepreneurs - Indian Chemical News
When Will Corteva Report Q1 2025 Earnings? Key Date Revealed - Stock Titan
With 88% institutional ownership, Corteva, Inc. (NYSE:CTVA) is a favorite amongst the big guns - simplywall.st
Is Corteva (CTVA) an Undervalued Stock to Invest in According to Goldman Sachs? - Insider Monkey
UBS maintains Buy rating on Corteva with $73 target By Investing.com - Investing.com Canada
UBS maintains Buy rating on Corteva with $73 target - Investing.com India
Does Corteva (CTVA) have Long Runway for Outperformance? - Insider Monkey
Genetically Modified Crops Market Outlook 2025-2032: Growth - openPR
Here's How Much $1000 Invested In Corteva 5 Years Ago Would Be Worth Today - Benzinga
Corteva Fails to Fast-Track Appeal in Syngenta Corn-Patent Suit - Bloomberg Law News
Where are the Opportunities in (CTVA) - Stock Traders Daily
DuPont, Corteva Can't Avoid Court Advisers' Damages Suggestions - Bloomberg Law News
Sunflower Seeds Market Growth in Future Scope 2025-2032 | Corteva, Inc., Groupe Limagrain, Kws Saat Se & Co. Kga - openPR
Corteva and Indiana State Fair reveal 2025 Featured Farmers - WBIW.com
New Partnership Automates Delivery of Customized Planting Prescriptions - Agweb Powered by Farm Journal
Specialty Pesticides Market Set for Rapid Growth and Trend - openPR
Corteva to phase out BMR corn hybrids - Ottumwa Radio
With 7.3% one-year returns, institutional owners may ignore Corteva, Inc.'s (NYSE:CTVA) 3.7% stock price decline - Yahoo Finance
Is Corteva Stock Outperforming the Dow? - Nasdaq
Goldman Sachs Agri Stock Picks: Corteva's R&D Edge, FMC's Pipeline, And Mosaic's Phosphate Advantage Set Up Strong Growth - AOL.com
Goldman Sachs initiates Corteva stock with Buy rating, $71 target By Investing.com - Investing.com Australia
Is Corteva Stock Outperforming The Dow? - Barchart
12 Analysts Assess Corteva: What You Need To Know - Benzinga
Berenberg Lifts Price Target on Corteva to $59 From $57, Keeps Hold Rating -March 13, 2025 at 06:41 am EDT - Marketscreener.com
Goldman Sachs initiates Corteva stock with Buy rating, $71 target - Investing.com
Corteva Inc. stock outperforms competitors despite losses on the day - MarketWatch
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.52%
1.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):